AR117462A1 - Vacuna contra norovirus, formulaciones y métodos - Google Patents
Vacuna contra norovirus, formulaciones y métodosInfo
- Publication number
- AR117462A1 AR117462A1 ARP190103785A ARP190103785A AR117462A1 AR 117462 A1 AR117462 A1 AR 117462A1 AR P190103785 A ARP190103785 A AR P190103785A AR P190103785 A ARP190103785 A AR P190103785A AR 117462 A1 AR117462 A1 AR 117462A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- formulations
- vaccine against
- against norovirus
- norovirus
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241001263478 Norovirus Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782733P | 2018-12-20 | 2018-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117462A1 true AR117462A1 (es) | 2021-08-04 |
Family
ID=71101884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103785A AR117462A1 (es) | 2018-12-20 | 2019-12-19 | Vacuna contra norovirus, formulaciones y métodos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220054621A1 (https=) |
| EP (1) | EP3897712A4 (https=) |
| JP (1) | JP2022514759A (https=) |
| KR (1) | KR20210114941A (https=) |
| CN (1) | CN113453711A (https=) |
| AR (1) | AR117462A1 (https=) |
| AU (1) | AU2019404430A1 (https=) |
| BR (1) | BR112021012181A2 (https=) |
| CA (1) | CA3123860A1 (https=) |
| CO (1) | CO2021009379A2 (https=) |
| IL (1) | IL284233A (https=) |
| MX (1) | MX2021007502A (https=) |
| SG (1) | SG11202106628YA (https=) |
| WO (1) | WO2020132510A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740624B (zh) | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| EP4112074A1 (en) | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| WO2022143282A1 (zh) * | 2020-12-30 | 2022-07-07 | 远大赛威信生命科学(南京)有限公司 | 诺如病毒病毒样颗粒、免疫组合物或试剂盒及其用途 |
| US20240238401A1 (en) | 2021-05-21 | 2024-07-18 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| WO2024202045A1 (ja) * | 2023-03-31 | 2024-10-03 | デンカ株式会社 | 腸管へのウイルス特異的な抗体誘導が可能なノロウイルスワクチン |
| WO2025076792A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Product Co., Ltd. | Methods of preparing norovirus vaccine with low amounts of adjuvant |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2514316T3 (es) * | 2005-11-22 | 2014-10-28 | Novartis Vaccines And Diagnostics, Inc. | Partículas similares a virus (VLPs) de Norovirus y Sapovirus |
| CN104740624B (zh) * | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| NO2324113T3 (https=) * | 2008-08-08 | 2018-07-28 | ||
| US20110070260A1 (en) * | 2009-09-09 | 2011-03-24 | Baric Ralph S | Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| CA2787666A1 (en) * | 2010-01-21 | 2011-07-28 | Ligocyte Pharmaceuticals, Inc. | Targeted heterologous antigen presentation on calicivirus virus-like particles |
| EP4112074A1 (en) * | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
-
2019
- 2019-12-19 AR ARP190103785A patent/AR117462A1/es not_active Application Discontinuation
- 2019-12-20 CA CA3123860A patent/CA3123860A1/en active Pending
- 2019-12-20 WO PCT/US2019/067961 patent/WO2020132510A1/en not_active Ceased
- 2019-12-20 BR BR112021012181-1A patent/BR112021012181A2/pt unknown
- 2019-12-20 SG SG11202106628YA patent/SG11202106628YA/en unknown
- 2019-12-20 KR KR1020217020497A patent/KR20210114941A/ko not_active Withdrawn
- 2019-12-20 AU AU2019404430A patent/AU2019404430A1/en active Pending
- 2019-12-20 MX MX2021007502A patent/MX2021007502A/es unknown
- 2019-12-20 CN CN201980092246.7A patent/CN113453711A/zh active Pending
- 2019-12-20 EP EP19901048.9A patent/EP3897712A4/en active Pending
- 2019-12-20 US US17/416,810 patent/US20220054621A1/en active Pending
- 2019-12-20 JP JP2021535827A patent/JP2022514759A/ja active Pending
-
2021
- 2021-06-20 IL IL284233A patent/IL284233A/en unknown
- 2021-07-19 CO CONC2021/0009379A patent/CO2021009379A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022514759A (ja) | 2022-02-15 |
| US20220054621A1 (en) | 2022-02-24 |
| SG11202106628YA (en) | 2021-07-29 |
| AU2019404430A1 (en) | 2021-07-08 |
| CN113453711A (zh) | 2021-09-28 |
| CO2021009379A2 (es) | 2021-08-30 |
| WO2020132510A1 (en) | 2020-06-25 |
| KR20210114941A (ko) | 2021-09-24 |
| BR112021012181A2 (pt) | 2021-08-31 |
| CA3123860A1 (en) | 2020-06-25 |
| IL284233A (en) | 2021-08-31 |
| EP3897712A4 (en) | 2022-08-31 |
| MX2021007502A (es) | 2021-10-13 |
| EP3897712A1 (en) | 2021-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR117462A1 (es) | Vacuna contra norovirus, formulaciones y métodos | |
| ECSP18001613A (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| BR112017001796A2 (pt) | composições de flagelina e seus usos | |
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| EP3668541A4 (en) | FORMULATIONS FOR PNEUMOCOCCAL CONJUGATE VACCINE | |
| PL3585803T3 (pl) | Formulacje skoniugowanych szczepionek przeciwko pneumokokom | |
| MX2018001755A (es) | Vacuna contra viruela para tratamiento del cancer. | |
| MX2019008564A (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas. | |
| MX388137B (es) | Formulaciones eutecticas de clorhidrato de ciclobenzaprina y de clorhidrato de amitriptilina. | |
| CR20140175A (es) | Compuestos y métodos para mejorar las respuestas inmunitarias innatas | |
| AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
| MX2022002106A (es) | Formulaciones de vacuna de vial unico. | |
| CL2015001111A1 (es) | Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna. | |
| MX2020011712A (es) | Vacunas de nanoparticulas multivalentes contra la influenza. | |
| MX2019005102A (es) | Poxvirus quimericos sinteticos. | |
| CU20180025A7 (es) | Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue | |
| MX2017005687A (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| MX2023012390A (es) | Vacunacion con particulas de replicon y adyuvante oleoso. | |
| CO2018010359A2 (es) | Constructos de alfavirus vivo atenuado y métodos y usos de los mismos | |
| MX2021005910A (es) | Formulacion de proteina de alta concentracion. | |
| PE20160596A1 (es) | Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana | |
| MX2022001430A (es) | Formulaciones de vacuna contra chikungu?a. | |
| BR112016012393A2 (pt) | Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |